Growth Metrics

Integra Lifesciences Holdings (IART) Free Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.54%
Dec 31, 2025 -120.96%
Sep 30, 2025 329.36%
Jun 30, 2025 72.06%
Mar 31, 2025 -290.05%
Dec 31, 2024 395.21%
Sep 30, 2024 -166.96%
Jun 30, 2024 3,574.91%
Mar 31, 2024 -99.15%
Dec 31, 2023 149.89%
Sep 30, 2023 7.55%
Jun 30, 2023 2.24%
Mar 31, 2023 -82.43%
Dec 31, 2022 19.81%
Sep 30, 2022 3.66%
Jun 30, 2022 62.97%
Mar 31, 2022 -16.32%
Dec 31, 2021 -44.56%
Sep 30, 2021 -10.82%
Jun 30, 2021 35.65%
Mar 31, 2021 -13.13%
Dec 31, 2020 14.18%
Sep 30, 2020 142.90%
Jun 30, 2020 503.03%
Mar 31, 2020 -93.59%
Dec 31, 2019 32.27%
Sep 30, 2019 64.12%
Jun 30, 2019 130.33%
Mar 31, 2019 -21.20%
Dec 31, 2018 -72.83%
Sep 30, 2018 286.00%
Jun 30, 2018 -37.99%
Mar 31, 2018 1,317.13%
Dec 31, 2017 -105.74%
Sep 30, 2017 133.28%
Jun 30, 2017 -18.48%
Mar 31, 2017 234.29%
Dec 31, 2016 -136.85%
Sep 30, 2016 33.48%
Jun 30, 2016 110.91%
Mar 31, 2016 12.71%
Dec 31, 2015 -11.99%
Sep 30, 2015 -53.39%
Jun 30, 2015 16.28%
Mar 31, 2015 475.93%
Dec 31, 2014 -128.36%
Sep 30, 2014 251.20%
Jun 30, 2014 8,767.90%
Mar 31, 2014 -101.18%
Dec 31, 2013 -60.77%
Sep 30, 2013 264.06%
Jun 30, 2013 -255.97%
Mar 31, 2013 89.29%
Dec 31, 2012 -442.71%
Sep 30, 2012 168.53%
Jun 30, 2012 -154.57%
Mar 31, 2012 1.18%
Dec 31, 2011 87.42%
Sep 30, 2011 -33.48%
Jun 30, 2011 13.27%
Mar 31, 2011 50.49%
Dec 31, 2010 -54.59%
Sep 30, 2010 1,202.38%
Jun 30, 2010 -94.94%
Mar 31, 2010 -4.69%
Dec 31, 2009 57.63%